Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation study. Issue 6 (8th March 2022)

• Record Type: Journal Article
• Authors: Stammers, Matthew; Rahmany, Sohail; Downey, Louise; Borca, Florina; Harris, Clare; Harris, Richard; McDonnell, Martin; Sartain, Stephanie; Coleman, Nicolas; Stacey, Bernard; Smith, Trevor R; Cummings, Fraser; Felwick, Richard; Gwiggner, Markus
• Is Part Of: Frontline gastroenterology. Volume 13:Issue 6(2022)
• Page Start: 477
• Page End: 483
• Publication Date: 2022-03-08
• Subjects: inflammatory bowel disease -- endoscopy; Gastroenterology -- Periodicals; 616.33005
• DOI: 10.1136/flgastro-2021-102047
• Languages: English
• ISSNs: 2041-4137

Abstract

Abstract : Introduction: Patients with suspected inflammatory bowel disease (IBD) referred from primary care often face diagnostic and treatment delays. This study aimed to compare a novel direct-access IBD endoscopy pathway with the traditional care model. Method: Single centre real-world study analysing primary care referrals with suspected IBD. Group A: patients triaged to direct-access IBD endoscopy. Group B: patients undergoing traditional outpatient appointments before the availability of direct-access IBD endoscopy. Demographics, fecal calprotectin (FCP), C-reactive protein (CRP), disease activity score, endoscopy findings, treatment and follow-up were collected and statistically analysed. Ranked semantic analysis of IBD symptoms contained within referral letters was performed. Results: Referral letters did not differ significantly in Groups A and B. Demographic data, FCP and CRP values were similar. Referral to treatment time (RTT) at the time of IBD endoscopy was reduced from 177 days (Group B) to 24 days (Group A) (p<0.0001). Diagnostic yield of IBD was 35.6% (Group B) versus 62.0% (Group A) (p=0.0003). 89.2% of patients underwent colonoscopy in Group B versus 46.4% in Group A. DNA rates were similar in both groups. The direct to IBD endoscopy pathway saved 100% of initial IBD consultant clinics with a 2.5-fold increase in IBD nurse-led follow-up. Conclusion: Our novel pathway resulted in an 86% reduction in RTT with associated increased diagnostic yield while saving 100% of initial IBD consultant outpatient appointments. Replication in other trusts may improve patient experience and accelerate time to diagnosis/treatment while optimising the use of healthcare resources.